Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication. The patent’s expiration means that cheaper, generic versions will soon hit pharmacy shelves. Currently, a month's supply of Lipitor costs $174.71 on average. For those with health insurance, the co-pay can run as high as $49. That co-pay will drop to $10 for generic Lipitor, and the off-the-shelf price for the uninsured will fall by as much as 90 percent.
SEE ALSO: Our Special Report on Navigating Medicare
Advertisement
To see who stands to benefit most from the switch, we mapped the cost of a month's supply of Lipitor in more than 300 cities around the country. East Coasters are in luck: Lipitor generally costs the most in their region, so they can expect to pocket the most money if they switch to a generic version.
Permission to post your comment is assumed when you submit it. The name you provide will be used to identify your post, and NOT your e-mail address. We reserve the right to excerpt or edit any posted comments for clarity, appropriateness, civility, and relevance to the topic.
View our full privacy policy